Physician profile
Jon Yost
NPI 1649385360
$523.03
in general payments reported to CMS, 2019-2025
8 companies · $24.06 in 2025
The $24.06 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $53.51 · 2021: $81.79 · 2022: $55.51 · 2023: $85.63 · 2024: $110 · 2025: $24.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $219.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $289.21 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $53.61 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $47.30 | 2019-2021 | |
| Sanofi Pasteur INC. | $46.81 | 2023-2024 | |
| Ironshore Pharmaceuticals INC. | $30.81 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $29.97 | 2021-2022 | |
| Shire North American Group INC | $13.59 | 2019 | |
| Abbvie INC. | $11.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Yost listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.